In this issue:
Aspirin for VTE prophylaxis after total hip and knee replacement
Testosterone therapy and VTE risk for men with and without hypogonadism
Tranexamic acid + factor VIII in severe hemophilia A
Clinical outcomes of isolated distal DVT vs proximal VTE in cancer patients
Caplacizumab in patients with exacerbations of acquired TTP
Unmet clinical needs in prophylaxis and treatment of VTE in at-risk patient groups
NOACs vs. VKAs in patients with AF and chronic kidney disease
Arterial thrombosis in Philadelphia-negative MPNs predicts second cancer
Updated meta-analysis on prevention of VTE in ambulatory cancer patients
Extended anticoagulation treatment vs standard treatment for the prevention of recurrent VTE and post-thrombotic syndrome
Please login below to download this issue (PDF)